Jeff Evanson was Appointed as Chief Commercial Officer at Outlook Therapeutics

Date of management change: December 03, 2018 

What Happened?

Cranbury, NJ-based Outlook Therapeutics Appointed Jeff Evanson as Chief Commercial Officer


About the Company

Oncobiologics, Inc. has changed its name to Outlook Therapeutics, Inc. Outlook Therapeutics is a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration (wet AMD). ONS-5010 is currently in its first clinical trial, which is being conducted outside of the U.S. and is designed to serve as the first of two adequate and well controlled studies for wet AMD.


About the Person

Jeff Evanson is Chief Commercial Officer at Outlook Therapeutics. Previously, Jeff held various senior marketing leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Grasso Davide, Cherry Daniel, Messinger Scott, Adams Scott, Irvin John, Perkins Jenn, Wolak Lance, Brower Susan, Bolander Larry, Kramer Amy, Scalabrino Robert

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.